Invesco Ltd. Aldeyra Therapeutics, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 501,137 shares of ALDX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

501,137

Previous 29,906 1575.71%

Holding current value

$1.04 Million

Previous $149,000 1833.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$4.7 - $6.98 $2.21 Million - $3.29 Million	471,231 Added 1575.71%	501,137 $2.88 Million
Q4 2024 Feb 13, 2025	SELL	$4.21 - $5.9 $2.64 Million - $3.7 Million	-626,604 Reduced 95.44%	29,906 $149,000
Q3 2024 Nov 12, 2024	BUY	$3.19 - $6.32 $2 Million - $3.96 Million	626,646 Added 2098.33%	656,510 $3.54 Million
Q2 2024 Aug 13, 2024	SELL	$3.25 - $4.72 $6,376 - $9,260	-1,962 Reduced 6.16%	29,864 $98,000
Q1 2024 May 14, 2024	BUY	$2.77 - $4.22 $168 - $257	61 Added 0.19%	31,826 $104,000
Q4 2023 Feb 12, 2024	SELL	$1.47 - $6.06 $23,980 - $98,856	-16,313 Reduced 33.93%	31,765 $111,000
Q3 2023 Nov 13, 2023	SELL	$6.11 - $8.16 $2.85 Million - $3.81 Million	-467,263 Reduced 90.67%	48,078 $321,000
Q2 2023 Aug 11, 2023	BUY	$7.11 - $11.89 $1.65 Million - $2.77 Million	232,635 Added 82.29%	515,341 $4.32 Million
Q1 2023 May 12, 2023	BUY	$5.77 - $9.93 $205,729 - $354,054	35,655 Added 14.43%	282,706 $2.81 Million
Q4 2022 Feb 13, 2023	BUY	$5.08 - $7.09 $97,612 - $136,234	19,215 Added 8.43%	247,051 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $865,776 - $1.76 Million	227,836 New	227,836 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $39,791 - $79,418	-16,375 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $1,228 - $1,954	-378 Reduced 2.26%	16,375 $73,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $23,117 - $63,606	-6,605 Reduced 28.28%	16,753 $67,000
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $46,107 - $65,677	5,807 Added 33.09%	23,358 $205,000
Q2 2021 Aug 17, 2021	BUY	$10.44 - $14.85 $183,232 - $260,632	17,551 New	17,551 $199,000
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $3.94 Million - $5.08 Million	-624,738 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $2.5 Million - $4.7 Million	624,738 New	624,738 $4.63 Million

Others Institutions Holding ALDX

# of Institutions

139

Shares Held

38.5M

Call Options Held

620K

Put Options Held

435K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $121M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account